Imbruvica Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Imbruvica
J
- Jadenu (deferasirox)
- Jadenu Sprinkle (deferasirox)
- Jakafi (ruxolitinib)
- Janssen COVID-19 Vaccine (sars-cov-2 (covid-19) ad26 vaccine, recombinant)
- Jantoven (warfarin)
- Janumet (metformin / sitagliptin)
- Janumet XR (metformin / sitagliptin)
- Januvia (sitagliptin)
- japanese enceph vacc sa14-14-2, inactivated
- japanese encephalitis virus vaccine nakayama
- Jaypirca (pirtobrutinib)
- Je-Vax (japanese encephalitis virus vaccine nakayama)
- Jentadueto (linagliptin / metformin)
- Jentadueto XR (linagliptin / metformin)
- Jubbonti (denosumab)
- Juvisync (simvastatin / sitagliptin)
- Juxtapid (lomitapide)
- Jynarque (tolvaptan)
- Jynneos (smallpox and monkeypox vaccine)
More about Imbruvica (ibrutinib)
- Imbruvica consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (61)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.